{"pmid":32464327,"title":"COVID-19 and Kawasaki Disease in Children.","text":["COVID-19 and Kawasaki Disease in Children.","Pharmacol Res","Xu, Suowen","Chen, Mingwu","Weng, Jianping","32464327"],"journal":"Pharmacol Res","authors":["Xu, Suowen","Chen, Mingwu","Weng, Jianping"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464327","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.phrs.2020.104951","keywords":["children","endothelial dysfunction","inflammation","kawasaki disease","sars-cov-2","vasculitis"],"locations":["Children"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1668079521318830080,"score":9.490897,"similar":[{"pmid":32462354,"title":"Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.","text":["Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.","There is a global concern of increasing number of children presenting with inflammatory syndrome with clinical features simulating Kawasaki disease, during ongoing COVID-19 pandemic. The authors report a very similar case of 5-y-old boy from a COVID-19 hotspot area who presented in late April 2020 with acute febrile illness with abdominal pain and loose stools followed by shock. On examination, child had bulbar conjunctivitis and extremity edema. Initial investigations showed high inflammatory parameters, elevated serum creatinine and liver enzymes. Echocardiography showed moderate LV dysfunction and normal coronaries. Cardiac enzymes were also elevated, suggesting myocarditis. He was treated with inotropic support, respiratory support with high flow nasal cannula, IV immunoglobulins, aspirin, steroids and diuretics. RT PCR for SARS-CoV-2 was negative twice. His clinical condition improved rapidly, was afebrile from day 2, inflammatory parameters decreased, left ventricular function improved and was discharged after 6 d of hospital stay.","Indian J Pediatr","Rauf, Abdul","Vijayan, Ajay","John, Shaji Thomas","Krishnan, Raghuram","Latheef, Abdul","32462354"],"abstract":["There is a global concern of increasing number of children presenting with inflammatory syndrome with clinical features simulating Kawasaki disease, during ongoing COVID-19 pandemic. The authors report a very similar case of 5-y-old boy from a COVID-19 hotspot area who presented in late April 2020 with acute febrile illness with abdominal pain and loose stools followed by shock. On examination, child had bulbar conjunctivitis and extremity edema. Initial investigations showed high inflammatory parameters, elevated serum creatinine and liver enzymes. Echocardiography showed moderate LV dysfunction and normal coronaries. Cardiac enzymes were also elevated, suggesting myocarditis. He was treated with inotropic support, respiratory support with high flow nasal cannula, IV immunoglobulins, aspirin, steroids and diuretics. RT PCR for SARS-CoV-2 was negative twice. His clinical condition improved rapidly, was afebrile from day 2, inflammatory parameters decreased, left ventricular function improved and was discharged after 6 d of hospital stay."],"journal":"Indian J Pediatr","authors":["Rauf, Abdul","Vijayan, Ajay","John, Shaji Thomas","Krishnan, Raghuram","Latheef, Abdul"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462354","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s12098-020-03357-1","keywords":["covid-19","children","inflammatory syndrome","kawasaki disease","multi-organ dysfunction"],"locations":["Kawasaki"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"e_drugs":["Aspirin","Steroids","Creatinine"],"topics":["Case Report"],"weight":1,"_version_":1668079521424736257,"score":64.33795},{"pmid":32455505,"title":"Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","text":["Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19.","J Eur Acad Dermatol Venereol","Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E","32455505"],"abstract":["We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19."],"journal":"J Eur Acad Dermatol Venereol","authors":["Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455505","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jdv.16666","keywords":["covid-19","kawasaki disease","coranovirus","erythema multiforme"],"locations":["Kawasaki","Kawasaki"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Case Report"],"weight":1,"_version_":1667881798469681153,"score":57.611603},{"pmid":32423291,"title":"Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.","text":["Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.","With the onset of the COVID-19 pandemic, many novel presentations of known conditions are occurring. In the pediatric population, new instances of Kawasaki disease have recently been singled out as presenting in conjunction with or soon after diagnosis of COVID-19. This poses a novel situation, particularly for otolaryngologists, who may be the first to encounter these patients. Otolaryngologists should be cognizant of the coexistence of conditions to allow for timely recognition and optimal management.","Otolaryngol Head Neck Surg","Sandhaus, Henya","Crosby, Dana","Sharma, Arun","Gregory, Stacie R","32423291"],"abstract":["With the onset of the COVID-19 pandemic, many novel presentations of known conditions are occurring. In the pediatric population, new instances of Kawasaki disease have recently been singled out as presenting in conjunction with or soon after diagnosis of COVID-19. This poses a novel situation, particularly for otolaryngologists, who may be the first to encounter these patients. Otolaryngologists should be cognizant of the coexistence of conditions to allow for timely recognition and optimal management."],"journal":"Otolaryngol Head Neck Surg","authors":["Sandhaus, Henya","Crosby, Dana","Sharma, Arun","Gregory, Stacie R"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423291","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/0194599820930238","keywords":["covid-19","ent","kawasaki disease","coronavirus","new presentation","otolaryngology","pediatrics"],"locations":["Kawasaki","Otolaryngologists","Otolaryngologists"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Prevention"],"weight":1,"_version_":1667352728900206592,"score":51.706455},{"pmid":32471782,"title":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.","text":["Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.","The 2019 coronavirus disease (COVID-19) has not appeared to affect children as severely as adults. However, approximately 1 month after the COVID-19 peak in New York City in April 2020, cases of children with prolonged fevers abruptly developing inflammatory shock-like states have been reported in Western Europe and the United States. This case series describes four previously healthy children with COVID-19 infection confirmed by serologic antibody testing, but negative by nasopharyngeal RT-PCR swab, presenting to the Pediatric Emergency Department (PED) with prolonged fever (5 or more days) and abrupt onset of hemodynamic instability with elevated serologic inflammatory markers and cytokine levels (IL-6, IL-8 and TNF-alpha). Emergency physicians must maintain a high clinical suspicion for this COVID-19 associated post-infectious cytokine release syndrome, with features that overlap with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS) in children with recent or current COVID-19 infection, as patients can decompensate quickly.","Am J Emerg Med","Waltuch, Temima","Gill, Prakriti","Zinns, Lauren E","Whitney, Rachel","Tokarski, Julia","Tsung, James W","Sanders, Jennifer E","32471782"],"abstract":["The 2019 coronavirus disease (COVID-19) has not appeared to affect children as severely as adults. However, approximately 1 month after the COVID-19 peak in New York City in April 2020, cases of children with prolonged fevers abruptly developing inflammatory shock-like states have been reported in Western Europe and the United States. This case series describes four previously healthy children with COVID-19 infection confirmed by serologic antibody testing, but negative by nasopharyngeal RT-PCR swab, presenting to the Pediatric Emergency Department (PED) with prolonged fever (5 or more days) and abrupt onset of hemodynamic instability with elevated serologic inflammatory markers and cytokine levels (IL-6, IL-8 and TNF-alpha). Emergency physicians must maintain a high clinical suspicion for this COVID-19 associated post-infectious cytokine release syndrome, with features that overlap with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS) in children with recent or current COVID-19 infection, as patients can decompensate quickly."],"journal":"Am J Emerg Med","authors":["Waltuch, Temima","Gill, Prakriti","Zinns, Lauren E","Whitney, Rachel","Tokarski, Julia","Tsung, James W","Sanders, Jennifer E"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471782","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ajem.2020.05.058","keywords":["covid-19","children","cytokine storm","kawasaki disease"],"locations":["New York","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1668255193350799361,"score":49.805573},{"pmid":32475003,"title":"The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.","text":["The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.","A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and May 15, 2019, and on 1 April and May 15, 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea. This article is protected by copyright. All rights reserved.","Dermatol Ther","Dursun, Recep","Temiz, Selami Aykut","32475003"],"abstract":["A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and May 15, 2019, and on 1 April and May 15, 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Dursun, Recep","Temiz, Selami Aykut"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475003","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/dth.13730","keywords":["covid-19","hhv-6","kawasaki disease","pityriasis rosea"],"locations":["Wuhan","China","Pityriasis","Kawasaki","Kawasaki","Pityriasis","Pityriasis","Kawasaki"],"countries":["China","Japan"],"countries_codes":["CHN|China","JPN|Japan"],"topics":["Prevention"],"weight":1,"_version_":1668341932654329856,"score":49.5493}]}